Early history of pathology studies by the Intergroup Rhabdomyosarcoma Study Group.
This review chronicles the series of publications that were the result of the willingness of pathologists and clinicians in the United States to share their pathologic materials and clinical data on patients who were placed on treatment protocols for rhabdomyosarcoma and related tumors over an extended period of time. The availability of this database enabled pathologists and clinicians to study a tumor type that is rare in individual institutions, but occurs in large enough numbers to produce valid conclusions not otherwise possible. Furthermore, young investigators were challenged by this opportunity and were able to spend the necessary time to make new observations that, in retrospect, helped direct protocol designs that produced significant improvement in patient survival. The key factor in this process is the surrender of individual scientific prerogatives to a small number of investigators. It is also important to recognize that the pathologist component of these series of contributions is only a part of the entire effort. It takes an organization of gifted, dedicated experts in many disciplines working together. The investigators who served on the Intergroup Rhabdomyosarcoma Group over a 25-year period eminently fulfilled this.
Newton
W A
WA
Department of Pathology, Children's Hospital, Columbus, OH 43205, USA.
Webber
B
B
Hamoudi
A B
AB
Gehan
E A
EA
Maurer
H M
HM
D002648:Child; D005257:Fellowships and Scholarships / Q000266:history; D049673:History, 20th Century; D006801:Humans; D010338:Pathology, Clinical / Q000266:history*; D012208:Rhabdomyosarcoma / Q000266:history* / Q000473:pathology; D012955:Societies, Medical / Q000266:history*